BCIQ Profiles

Company Profile ReportTarget Profile Report

Wound-up bacteria

Ilya delivers CXCL12 via engineered bacteria to speed wound healing

Ilya Pharma AB has engineered bacteria to produce a protein that promotes wound closure as a more convenient and lower cost alternative to recombinant protein therapies that accelerate wound healing.

According to CEO Evelina Vågesjö, the standard of care to treat wounds involves cleaning the wound site and re-dressing the wound about every three days. For acute wounds, antibiotics may be added to

Read the full 632 word article

How to gain access

Continue reading with a
two-week free trial.